Assessing adjuvant breast cancer therapy benefit

Comment

A M Sleeper. J Clin Oncol. 2001.

. 2001 Jun 15;19(12):3157-8; author reply 3158-9.

doi: 10.1200/JCO.2001.19.12.3157.

No abstract available

Comment on

Understanding the utility of adjuvant systemic therapy for primary breast cancer.
Loprinzi CL, Thomé SD. Loprinzi CL, et al. J Clin Oncol. 2001 Feb 15;19(4):972-9. doi: 10.1200/JCO.2001.19.4.972. J Clin Oncol. 2001. PMID: 11181659
Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy.
Braun S, Cevatli BS, Assemi C, Janni W, Kentenich CR, Schindlbeck C, Rjosk D, Hepp F. Braun S, et al. J Clin Oncol. 2001 Mar 1;19(5):1468-75. doi: 10.1200/JCO.2001.19.5.1468. J Clin Oncol. 2001. PMID: 11230493